Skip to main content
Clinical Trials/NCT04542486
NCT04542486CompletedNot Applicable

Clinical Efficacy of Soft Tissue Trimmer on Postoperative Pain and Wound Healing When Compared to the Conventional Surgical Excision of Gingival Hyperplasia: A Randomized Clinical Trial

Cairo University1 site in 1 country28 target enrollmentStarted: January 28, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
28
Locations
1
Primary Endpoint
Pain VAS

Study Overview

Brief Summary

Postoperative pain and wound healing are compared after using conventional scalpel technique in comparison with the intervention which is using Soft tissue Trimmer for cases of gingival hyperplasia.

Detailed Description

In the control group:

  1. Following the local anaesthetic administration, A reverse bevel gingivectomy will be performed with a #15c scalpel.
  2. The borderline of gingiva will be determined via the use of a pointer dental tweezers, and excessive gingival tissue will then be removed with Gracey curettes
  3. No periodontal packs to be applied to ensure accurate evaluations of follow-up pain and wound healing

In the intervention group:

  1. Following the local anaesthetics administration for the Soft tissue trimmer(STT) gingivectomies, Soft tissue trimmer will be used with 400-rpm rotary systems and with no serum irrigation, per the manufacturer's recommendation.
  2. Gingivoplasties will be performed with the same Soft tissue trimmer to easily provide a knife-edge appearance.
  3. No periodontal packs will be applied to ensure accurate evaluations of follow-up pain and wound healing.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Anterior region (minimum of four teeth at each surgical site)
  • Age range (18-45) years old
  • Plaque-induced inflammatory gingival enlargement
  • Altered passive eruption
  • No clinical attachment loss
  • Systemically healthy individuals

Exclusion Criteria

  • Gingival enlargement due to any systemic predisposing factors
  • Pregnancy and/or lactation
  • Conditions requiring antibiotic prophylaxis and anti-inflammatory medications.
  • Acute or untreated periodontitis
  • Systemic disease that could influence the outcome of the treatment (i.e. Diabetes)

Outcomes

Primary Outcomes

Pain VAS

Time Frame: 7 days

Visual Analogue Scale for Pain (numbers from 0 to 10 ('no pain' to 'worst pain imaginable') measured 1,3,5 and 7 days postoperatively.

Secondary Outcomes

  • Bleeding(From 3-5 days)
  • Epithelization(14 days.)
  • Tissue colour(6 weeks.)
  • Surgical time(During surgical procedure itself.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mai Mohamed Sameh

Principal Investigator

Cairo University

Study Sites (1)

Loading locations...

Similar Trials